We often have posts that research claims for Viraleze are not valid because Starpharma didn't arrange independant, large enough trials, and they lacked medical journal articles and the PEER REVIEW.
Seems in 2020 both The Lancet and New England Journal were caught out by fake peer reviews on two covid treatments which even claimed large FAKE worldwide data sets even including imaginary Australian Hospitals data and the means to check this info and its supposed de identification of included participants was all a con.
https://www.theguardian.com/world/2020/jun/03/covid-19-surgisphere-who-world-health-organization-hydroxychloroquine most important factor was they they lacked "peer review"
Maybe the reported evidence for Viraleze efficacy reported at conferences, by Schripp Institute and the UK NHS Hosp Ashford St Peters study should inform TGA about the covid viral load reductions without waiting for Peer Review.
Is a Peer Review required for Viraleze covid viral load claim?
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.001(1.01%) |
Mkt cap ! $41.81M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $13.21K | 132.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 292303 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 324662 | 10 |
View Market Depth
| Last trade - 15.12pm 11/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |